V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005465 | 220002137 | 1.77 | 0 | Disease modification (D) | 2013-12-21 | 2013-12-21 | Trial Unspecified | Y | N | 220028245 | TRIAL |
| 220005466 | 220002137 | 1.55 | 78.5 | Not known (9) | null | 2013-01-11 | AML17 TRIAL | N | null | 220028245 | AML17 TRIAL |
| 220005467 | 220002138 | 1.79 | null | null | 2017-05-07 | 2017-05-07 | AML17 TRIAL | 01 | N | 220028248 | AML17 TRIAL |
| 220005468 | 220002138 | null | 103.8 | Curative (C) | null | 2017-03-25 | AML17 TRIAL | null | null | 220028248 | AML17 TRIAL |
| 220005469 | 220002139 | 1.84 | null | null | null | 2016-08-03 | Cytarabine Low Dose | 2 | null | 220028256 | CYTARABINE |
| 220005470 | 220002140 | 1.7 | 60.2 | Curative (C) | 2016-08-12 | 2016-08-12 | AML17 TRIAL | Y | N | 220028257 | AML17 TRIAL |
| 220005471 | 220011161 | 1.78 | null | Curative (C) | 2015-04-14 | 2015-04-15 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 220028258 | CYTARABINE |
| 220005472 | 220011161 | null | 58.4 | Curative (C) | 2017-05-12 | 2017-05-12 | AML17 TRIAL | null | N | 220028258 | AML17 TRIAL |
| 220005473 | 220002141 | null | null | Disease modification (D) | 2015-03-20 | 2015-03-20 | CYTARABINE | N | N | 220028261 | CYTARABINE |
| 220005474 | 220002142 | null | 56.3 | Curative (C) | 2013-03-06 | 2013-03-06 | AML17 TRIAL | 1 | N | 220028266 | AML17 TRIAL |
| 220005475 | 220002142 | 1.63 | 51.2 | Not known (9) | 2014-11-16 | 2014-11-21 | Trial Unspecified | Y | N | 220028266 | TRIAL |
| 220005479 | 220002144 | 0 | null | null | 2017-11-25 | 2017-11-26 | AML17 TRIAL | Y | null | 220028272 | AML17 TRIAL |
| 220005480 | 220011164 | 1.6 | 70.4 | Disease modification (D) | 2015-02-05 | 2015-02-05 | Trial Unspecified | Y | N | 220028273 | TRIAL |
| 220005481 | 220011164 | 0 | 80.7 | Palliative (P) | 2014-06-24 | 2014-06-26 | Cytarabine Low Dose | 99 | N | 220028273 | CYTARABINE |
| 220005482 | 220011164 | null | 65.9 | Curative (C) | 2013-01-31 | 2013-02-01 | AML17 TRIAL | null | N | 220028273 | AML17 TRIAL |
| 220005483 | 220002145 | 1.68 | 74.7 | Curative (C) | 2013-05-20 | 2013-05-21 | AML17 TRIAL | Y | null | 220028281 | AML17 TRIAL |
| 220005484 | 220011165 | 1.59 | 72.3 | Palliative (P) | 2016-12-04 | 2016-12-06 | Trial Unspecified | Y | N | 220028284 | TRIAL |
| 220005485 | 220002146 | 1.7 | 56.3 | Not known (9) | 2016-09-12 | 2016-09-16 | AML17 TRIAL | Y | N | 220028290 | AML17 TRIAL |
| 220005486 | 220002146 | 1.78 | 57.2 | Curative (C) | null | 2017-03-17 | AML17 TRIAL | null | null | 220028290 | AML17 TRIAL |
| 220005487 | 220002146 | 1.73 | 66.9 | null | 2016-08-12 | 2016-08-19 | Trial Unspecified | N | N | 220028290 | TRIAL |
| 220005488 | 220002147 | 1.72 | 0 | Palliative (P) | 2016-12-06 | 2016-12-06 | Cytarabine Low Dose | 02 | null | 220028302 | CYTARABINE |
| 220005489 | 220002148 | 1.55 | 147.9 | Palliative (P) | null | 2017-07-10 | Cytarabine Low Dose | N | N | 220028303 | CYTARABINE |
| 220005490 | 220011167 | 1.83 | 83 | Curative (C) | 2017-01-14 | 2017-01-16 | LI-1 TRIAL | Y | N | 220028304 | TRIAL |
| 220005491 | 220011167 | 1.69 | 88.6 | Curative (C) | 2014-11-15 | 2014-11-17 | Trial Unspecified | Y | N | 220028304 | TRIAL |
| 220005492 | 220002149 | null | null | Disease modification (D) | 2015-09-19 | 2015-10-02 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028309 | CYTARABINE |
| 220005493 | 220011168 | 0 | 71 | Palliative (P) | 2017-10-19 | 2017-10-19 | CYTARABINE | N | N | 220028311 | CYTARABINE |
| 220005494 | 220002150 | 1.6 | 64.4 | Curative (C) | 2013-08-14 | 2013-08-14 | Trial Unspecified | 01 | N | 220028324 | TRIAL |
| 220005495 | 220002150 | 1.62 | null | Palliative (P) | null | 2016-08-09 | Cytarabine Low Dose | null | null | 220028324 | CYTARABINE |
| 220005496 | 220002150 | null | 89.6 | Palliative (P) | 2014-03-25 | 2014-03-25 | Trial Unspecified | 1 | N | 220028324 | TRIAL |
| 220005497 | 220002151 | 1.74 | 74 | Curative (C) | 2014-10-28 | 2014-11-04 | Cytarabine Low Dose | 2 | N | 220028329 | CYTARABINE |
| 220005498 | 220002152 | 1.61 | null | null | 2013-02-27 | 2013-02-28 | Cytarabine Low Dose | 02 | N | 220028330 | CYTARABINE |
| 220005499 | 220002153 | 1.7 | null | Disease modification (D) | 2013-09-13 | 2013-09-13 | Cytarabine Low Dose | null | null | 220028331 | CYTARABINE |
| 220005500 | 220002153 | 1.78 | 105 | Curative (C) | null | 2013-04-12 | Cytarabine Low Dose | null | null | 220028331 | CYTARABINE |
| 220005501 | 220002153 | 1.73 | null | Curative (C) | null | 2017-09-10 | Trial Unspecified | null | null | 220028331 | TRIAL |
| 220005502 | 220021221 | 1.71 | 74.5 | Curative (C) | 2015-03-24 | 2015-03-27 | Trial Unspecified | Y | null | 220028338 | TRIAL |
| 220005503 | 220021713 | null | null | Curative (C) | 2015-07-13 | 2015-07-13 | Cytarabine Low Dose | N | N | 220028339 | CYTARABINE |
| 220005504 | 220021713 | 1.73 | 84.2 | Curative (C) | null | 2013-04-25 | AML17 TRIAL | null | null | 220028339 | AML17 TRIAL |
| 220005510 | 220002155 | 1.66 | 77.2 | Curative (C) | 2014-06-12 | 2014-06-19 | AML17 TRIAL | 01 | N | 220028355 | AML17 TRIAL |
| 220005511 | 220002155 | 1.71 | null | Palliative (P) | 2013-06-28 | 2013-08-08 | Cytarabine Low Dose | Y | N | 220028355 | CYTARABINE |
| 220005514 | 220002156 | null | null | Palliative (P) | 2016-03-06 | 2016-03-06 | Trial Unspecified | Y | N | 220028364 | TRIAL |
| 220005515 | 220011173 | null | 119.8 | Curative (C) | 2016-12-05 | 2016-12-05 | AML17 TRIAL | 1 | N | 220028367 | AML17 TRIAL |
| 220005516 | 220002157 | 1.74 | null | Palliative (P) | 2015-02-07 | 2015-02-08 | Cytarabine low (10to20mg/m2) IV/SC | null | N | 220028369 | CYTARABINE |
| 220005517 | 220002157 | 1.5 | 111 | Curative (C) | 2014-11-02 | 2014-11-06 | AML17 TRIAL | 01 | N | 220028369 | AML17 TRIAL |
| 220005518 | 220002158 | null | 135 | null | 2015-04-15 | 2015-04-20 | AML17 TRIAL | null | null | 220028374 | AML17 TRIAL |
| 220005519 | 220011175 | 1.75 | null | Palliative (P) | 2015-02-14 | 2015-02-14 | CYTARABINE | N | N | 220028376 | CYTARABINE |
| 220005520 | 220002159 | null | 81.4 | Not known (9) | 2013-08-18 | 2013-08-19 | LI-1 TRIAL | null | null | 220028378 | TRIAL |
| 220005521 | 220002159 | 0 | 41.9 | Palliative (P) | 2016-11-23 | 2016-11-23 | Trial Unspecified | Y | N | 220028378 | TRIAL |
| 220005522 | 220015984 | 1.53 | 80 | Curative (C) | 2017-07-21 | 2017-08-04 | AML17 TRIAL | null | N | 220028384 | AML17 TRIAL |
| 220005523 | 220002160 | 1.74 | 65.9 | Curative (C) | 2017-11-07 | 2017-11-14 | AML17 TRIAL | Y | null | 220028388 | AML17 TRIAL |
| 220005524 | 220002160 | 1.77 | 91 | Curative (C) | 2014-09-03 | 2014-09-03 | Trial Unspecified | 01 | N | 220028388 | TRIAL |